Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marte F van der Bijl

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Case Reports in Women'S Health|October 30, 2024
Balancing health and safety: Cardiovascular medications during pregnancy and lactationMarte F van der Bijl, Koen Verdonk, Jeanine E Roeters van Lennep
BMJ Open|November 12, 2024
FUPEC study, a prospective open-cohort on severe pre-eclampsia and cardiovascular risk factors based in the NetherlandsMarte F van der Bijl, Linda Al-Hassany, Anne I Wijtzes, et al.
Case Reports in Women'S Health|March 2, 2023
Effects of menstruation on the onset of acute coronary syndrome in premenopausal women: A case seriesMarte F van der Bijl, Madoka Sunamura, Nienke Ter Hoeve, et al.
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse eventsMarte F van der Bijl, Ruben J M Mijnster, P Hugo M van der Kuy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 12, 2025
A comprehensive analysis of female participation in cardiovascular trials involving the WCN investigator networkMarte F van der Bijl, Jeanine E Roeters van Lennep, Astrid Schut, et al.
European Heart Journal. Acute Cardiovascular Care|February 4, 2026
Impact of Female Underrepresentation in Trials Investigating Long-Term Pharmacologic Therapy after Acute Coronary Syndrome A Meta-analysis and Meta-regressionMarte F van der Bijl, Lotte Paulis, Hester M den Ruijter, et al.
Current Atherosclerosis Reports|January 28, 2025
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in WomenJulie A E van Oortmerssen, Janneke W C M Mulder, Marte F van der Bijl, et al.
Atherosclerosis|September 23, 2025
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group studyRuben J M Mijnster, Marte F van der Bijl, Amber Niesthoven, et al.
Atherosclerosis|May 28, 2026
Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trialsMarte F van der Bijl, Linda M Beens, Yolande Appelman, et al.
BMC Women'S Health|April 28, 2022
Perceived determinants of physical activity among women with prior severe preeclampsia: a qualitative assessmentLili L Kókai, Marte F van der Bijl, Martin S Hagger, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Case Reports in Women'S Health|October 30, 2024
Balancing health and safety: Cardiovascular medications during pregnancy and lactationMarte F van der Bijl, Koen Verdonk, Jeanine E Roeters van Lennep
BMJ Open|November 12, 2024
FUPEC study, a prospective open-cohort on severe pre-eclampsia and cardiovascular risk factors based in the NetherlandsMarte F van der Bijl, Linda Al-Hassany, Anne I Wijtzes, et al.
Case Reports in Women'S Health|March 2, 2023
Effects of menstruation on the onset of acute coronary syndrome in premenopausal women: A case seriesMarte F van der Bijl, Madoka Sunamura, Nienke Ter Hoeve, et al.
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse eventsMarte F van der Bijl, Ruben J M Mijnster, P Hugo M van der Kuy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 12, 2025
A comprehensive analysis of female participation in cardiovascular trials involving the WCN investigator networkMarte F van der Bijl, Jeanine E Roeters van Lennep, Astrid Schut, et al.
European Heart Journal. Acute Cardiovascular Care|February 4, 2026
Impact of Female Underrepresentation in Trials Investigating Long-Term Pharmacologic Therapy after Acute Coronary Syndrome A Meta-analysis and Meta-regressionMarte F van der Bijl, Lotte Paulis, Hester M den Ruijter, et al.
Current Atherosclerosis Reports|January 28, 2025
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in WomenJulie A E van Oortmerssen, Janneke W C M Mulder, Marte F van der Bijl, et al.
Atherosclerosis|September 23, 2025
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group studyRuben J M Mijnster, Marte F van der Bijl, Amber Niesthoven, et al.
Atherosclerosis|May 28, 2026
Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trialsMarte F van der Bijl, Linda M Beens, Yolande Appelman, et al.
BMC Women'S Health|April 28, 2022
Perceived determinants of physical activity among women with prior severe preeclampsia: a qualitative assessmentLili L Kókai, Marte F van der Bijl, Martin S Hagger, et al.
Pageof 2